"Meridian's Endwell, NY, location conducts research for a broad range of investigational treatments. Meridian partners with Endwell Family Physicians to offer studies that explore vaccines and medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions."

During the past decade, Meridian Clinical Research LLC conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 6 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 6 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meridian Clinical Research LLC" #1 sponsor was "ModernaTX, Inc." with 8 trials, followed by "Pfizer" with 6 trials sponsored, "Janssen Vaccines & Prevention B.V." with 3 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "BioNTech SE" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridian Clinical Research LLC" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator, "OSTAtistics" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Meridian Clinical Research LLC" are "COVID-19" (4 trials), "SARS-CoV-2 Infection" (4 trials), "Respiratory Syncytial Virus" (3 trials), "Seasonal Influenza" (3 trials) and "Influenza, Human" (2 trials). Many other conditions were trialed in "Meridian Clinical Research LLC" in a lesser frequency.

Most popular intervention types in "Meridian Clinical Research LLC" are "Biological" (21 trials), "Drug" (7 trials), "Other" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "mRNA-1010" (3 trials), "mRNA-1345" (3 trials), "Active Comparator" (2 trials) and "Ad26.COV2.S" (2 trials). Other intervention names were less common.

The vast majority of trials in "Meridian Clinical Research LLC" are 26 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Meridian Clinical Research LLC". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Meridian Clinical Research LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Meridian Clinical Research LLC, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".